These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10851066

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 4. Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
    Veeramani S, Yuan TC, Chen SJ, Lin FF, Petersen JE, Shaheduzzaman S, Srivastava S, MacDonald RG, Lin MF.
    Endocr Relat Cancer; 2005 Dec 01; 12(4):805-22. PubMed ID: 16322323
    [Abstract] [Full Text] [Related]

  • 5. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
    Lee MS, Igawa T, Yuan TC, Zhang XQ, Lin FF, Lin MF.
    Oncogene; 2003 Feb 06; 22(5):781-96. PubMed ID: 12569372
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
    Arnoldussen YJ, Lorenzo PI, Pretorius ME, Waehre H, Risberg B, Maelandsmo GM, Danielsen HE, Saatcioglu F.
    Cancer Res; 2008 Nov 15; 68(22):9255-64. PubMed ID: 19010898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ.
    BJU Int; 2006 Jan 15; 97(1):170-8. PubMed ID: 16336351
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase.
    Lin MF, Meng TC.
    Biochem Biophys Res Commun; 1996 Sep 04; 226(1):206-13. PubMed ID: 8806615
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF.
    Endocr Relat Cancer; 2006 Mar 04; 13(1):151-67. PubMed ID: 16601285
    [Abstract] [Full Text] [Related]

  • 15. Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells.
    Lin MF, Garcia-Arenas R, Kawachi M, Lin FF.
    Cell Mol Biol Res; 1993 Mar 04; 39(8):739-50. PubMed ID: 7951413
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C pathway is involved in regulating the secretion of prostatic acid phosphatase in human prostate cancer cells.
    Lin MF, Zhang XQ, Dean J, Lin FF.
    Cell Biol Int; 2001 Mar 04; 25(11):1139-48. PubMed ID: 11913958
    [Abstract] [Full Text] [Related]

  • 17. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X, Qin J, Xie Y, Khan O, Dowd F, Scofield M, Lin MF, Tu Y.
    Oncogene; 2006 Jun 22; 25(26):3719-34. PubMed ID: 16449965
    [Abstract] [Full Text] [Related]

  • 18. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 19. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C.
    Cancer Res; 2002 Nov 01; 62(21):6039-44. PubMed ID: 12414626
    [Abstract] [Full Text] [Related]

  • 20. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
    Di Lorenzo G, Tortora G, D'Armiento FP, De Rosa G, Staibano S, Autorino R, D'Armiento M, De Laurentiis M, De Placido S, Catalano G, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2002 Nov 01; 8(11):3438-44. PubMed ID: 12429632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.